These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17270276)
1. Tryptophan breakdown pathway in bipolar mania. Myint AM; Kim YK; Verkerk R; Park SH; Scharpé S; Steinbusch HW; Leonard BE J Affect Disord; 2007 Sep; 102(1-3):65-72. PubMed ID: 17270276 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Miller CL; Llenos IC; Dulay JR; Weis S Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631 [TBL] [Abstract][Full Text] [Related]
3. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Miller CL; Llenos IC; Cwik M; Walkup J; Weis S Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600 [TBL] [Abstract][Full Text] [Related]
4. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223 [TBL] [Abstract][Full Text] [Related]
5. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952 [TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. Barry S; Clarke G; Scully P; Dinan TG J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404 [TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway in major depression: evidence of impaired neuroprotection. Myint AM; Kim YK; Verkerk R; Scharpé S; Steinbusch H; Leonard B J Affect Disord; 2007 Feb; 98(1-2):143-51. PubMed ID: 16952400 [TBL] [Abstract][Full Text] [Related]
13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
14. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation. Keck PE; Hsu HA; Papadakis K; Russo J Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854 [TBL] [Abstract][Full Text] [Related]
15. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
16. The effect of allopurinol on the kynurenine formation in humans following a tryptophan load. Møller SE; Kirk L Acta Vitaminol Enzymol; 1978; 32(5-6):159-62. PubMed ID: 583196 [TBL] [Abstract][Full Text] [Related]
18. Corpus callosum areas in first-episode patients with bipolar disorder. Atmaca M; Ozdemir H; Yildirim H Psychol Med; 2007 May; 37(5):699-704. PubMed ID: 17224093 [TBL] [Abstract][Full Text] [Related]
19. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537 [TBL] [Abstract][Full Text] [Related]
20. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]